| P50 | author | Regina Hofmann-Lehmann | Q47452489 |
| | David C. Montefiori | Q63302725 |
| P2093 | author name string | Agnès-Laurence Chenine | |
| | Ruth M Ruprecht | |
| | Harold M McClure | |
| | Daniel C Anderson | |
| | Josef Vlasak | |
| | Pei-Lin Li | |
| | Timothy W Baba | |
| P2860 | cites work | Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120 | Q28646835 |
| | Persistent infection of macaques with simian-human immunodeficiency viruses | Q28775731 |
| | Viremia and AIDS in rhesus macaques after intramuscular inoculation of plasmid DNA encoding full-length SIVmac239. | Q33328470 |
| | Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2) | Q33640139 |
| | Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins | Q33783353 |
| | Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time | Q33787256 |
| | Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo | Q33813212 |
| | Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo | Q33821658 |
| | Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys | Q33839485 |
| | Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV) | Q34060230 |
| | Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding | Q35845976 |
| | Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques | Q35860556 |
| | An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys | Q35860563 |
| | A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. | Q35870467 |
| | Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1 | Q35880498 |
| | Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys | Q35885915 |
| | Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein | Q36549382 |
| | Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. | Q36649240 |
| | Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions | Q36650881 |
| | Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120 | Q36690500 |
| | Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques | Q36702206 |
| | Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression | Q36828930 |
| | Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135. | Q36884493 |
| | Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies | Q38363048 |
| | Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques | Q39185652 |
| | Escape of HIV-1 is associated with lack of V3 domain-specific antibodies in vivo | Q39439107 |
| | The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain | Q39439112 |
| | Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing | Q39457075 |
| | Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course | Q39605628 |
| | Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. | Q39869632 |
| | Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. | Q40832863 |
| | Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques | Q40965809 |
| | Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses | Q40965814 |
| | Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain | Q41063393 |
| | Initial characterization of viral sequences from a SHIV-inoculated pig-tailed macaque that developed AIDS. | Q42526189 |
| | An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization | Q43451743 |
| | Neuropathogenesis of Chimeric Simian/Human Immunodeficiency Virus infection In Pig‐tailed and Rhesus Macaques | Q44305282 |
| | Characterization of immune escape viruses from a macaque immunized with live-virus vaccine and challenged with pathogenic SHIVKU-1. | Q45739989 |
| | Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection | Q45744790 |
| | A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism | Q45762822 |
| | Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins | Q45865515 |
| | A role for carbohydrates in immune evasion in AIDS. | Q47982875 |
| | Utility of SHIV for testing HIV-1 vaccine candidates in macaques. | Q52845792 |
| | Fine specificity of antibody recognition may predict amino acid substitution in the third variable region of gp120 during HIV type 1 infection | Q70929822 |
| | Mucosal infection of neonatal rhesus monkeys with cell-free SIV | Q72146271 |
| | Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques | Q73379005 |
| | SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine | Q73480875 |
| | Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems | Q74220155 |
| | Oral transmission of primate lentiviruses | Q74659468 |
| | Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS | Q77222545 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 5278-5284 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage | |
| P478 | volume | 76 | |